Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-11 of 11 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
COVID-19 in Abadan University of Medical Sciences
Design:
A parallel randomized double blind clinical (...) :
Inclusion criteria: Patients who are diagnosed as Covid-19 patients by positive PCR test or by CT Scan (...) groups:
Intervention Group: Patients with Covid-19 that will be Recipient of standard national protocol
Study aim:
The effect of naproxen on the healing process of COVID-19 patients
Design:
This double (...) :
Inclusion criteria: COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive (...) with Covid19 (improvement of fever, chills, cough and night sweats)
clinical trial. The study population includes all patients with COVID-19 referring to Abadan hospitals. All (...) severe symptoms of COVID-19 who were admitted to the infectious ward of Ayatollah Taleghani Hospital in (...)COVID-19 with severe symptoms and positive RT-PCR assay of nasopharyngeal samples
Exclusion criteria
criteria:
COVID-19 patients that have positive PCR test
COVID-19 patients that have positive by CT Scan for COVID-19.
Exclusion criteria: Pregnant or breast feeding women, Patients under 18 years of age (...) laboratory findings in patients with coronary hospitalization in Abadan hospitals.
Design:
Clinical trial
inflammatory biomarkers in patients with COVID-19
Design:
Clinical trial with control group, with parallel (...) performed on 88 patients with Covid-19 referring to the clinic of Razi Hospital in Ahvaz. Patients are (...) .
Participants/Inclusion and exclusion criteria:
Patients aged 18 to 65 years Laboratory confirmation of Covid-19
Ayatollah Taleghani Hospital in Abadan. The study was performed on 100 patients with COVID-19 who were (...) Study aim:
Comparison of the administration of vitamin D3 and N acetylcysteine tablets in COVID-19(...) /Inclusion and exclusion criteria:
Inclusion criteria: COVID-19 patients that have positive PCR test of
myokin profile of patients improved from COVID-19
Design:
Clinical trial has three groups of selected (...) improved female patients from Covid19 who declare their readiness by recall, 33 people were selected based (...) /Inclusion and exclusion criteria:
Inclusion criteria: recovered individuals from COVID-19; Women between the
Study aim:
Determination of the effect of sofosbuvir/daclatasvir in COVID-19 patients
Design:
A clinical trial with a, with parallel control group, double-blind, randomized, phase 3, and multicenter groups per 1000 patients.
Settings and conduct:
The study is a double-blind clinical trial. The sample
patients of COVID-19
Design:
This research is a clinical trial, semi-experimental field type. Among the male patients recovered from COVID--19 , 24 people are voluntarily selected under the supervision of a (...) , study population: patients with COVID-19, blinding is not done in this study.
Participants/Inclusion
control group, two-way blind, randomly, simple random method on 40 patients with COVID19.
Settings and (...)Abadan University of Medical Sciences. Reflexology sessions for the intervention group will be held for 6
Study aim:
Evaluation of the effectiveness of sweet almond, oral product in improving Respiratory symptoms of patients with Quaid 19
Design:
This study is a Controlled Clinical Trial that is performed on 60 patients with COVID19, with respiratory symptoms. Patients were divided into two random groups using a table of random numbers and and a code assigned to them. The intervention group receive sweet almond oral product and the prescribed drugs according to protocol and for the control group, given only prescription drugs according to protocol.
Settings and conduct:
Patients who have been hospitalized with coronavirus diagnosis, at Masih Daneshvari Hospital in Tehran and have any respiratory symptoms receive 10 cc of oral almonds sweet product after each meal for 6 days. by.
The severity of dyspnea, cough and sleep quality,is evaluated with, questionnaire Dyspnoea, Leicester Cough questionnaire and
The Petersburg Questionnaire and recorded.
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
All patients with corona (confirmed by test or CT) two years and older of both sexes who have one of the clinical manifestations (shortness of breath and cough).
Exclusion criteria:
Any allergies to Almonds sweet or other foods
Diabetic patients Taking
Hospitalization in the intensive care unit
Intervention groups:
Patients with COVID19, who have any respiratory symptoms, receive oral product of sweet almond and prescription drugs, and the control group is given only prescription drugs.
Main outcome variables:
almond sweet
shortness of breath
cough Intensity